 TEL AVIV, Israel, Nov. 02, 2020 GLOBE NEWSWIRE -- VBL Therapeutics Nasdaq: VBLT, a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today announced that it will host a conference call and live audio webcast on Monday, November 16, 2020 at 8:30am Eastern Time to report third quarter ended September 30, 2020 financial results and to provide a corporate update. 